Raelipskie Partnership’s iShares Biotechnology ETF IBB Stock Holding History

Raelipskie Partnership’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1M	Sell	5,280 -1,395	-21%	-$240K	0.38%	51
2026 Q1	$1.13M	Sell	6,675 -2,085	-24%	-$357K	0.48%	44
2025 Q4	$1.48M	Sell	8,760 -1,013	-10%	-$165K	0.62%	37
2025 Q3	$1.41M	Sell	9,773 -2,275	-19%	-$311K	0.61%	38
2025 Q2	$1.52M	Sell	12,048 -975	-7%	-$120K	0.7%	35
2025 Q1	$1.67M	Sell	13,023 -53,120	-80%	-$7.2M	0.86%	29
2024 Q4	$8.74M	Sell	66,143 -1,659	-2%	-$233K	4.34%	7
2024 Q3	$9.87M	Buy	67,802 +5	+0%	+$723	4.81%	7
2024 Q2	$9.31M	Buy	67,797 +425	+0.6%	+$56.7K	4.97%	6
2024 Q1	$9.24M	Buy	67,372 +1,729	+3%	+$236K	5.27%	6
2023 Q4	$8.92M	Buy	+65,643	New	+$8.01M	5.43%	4

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Raelipskie Partnership's IBB Position: Q2 2026 in Review

Raelipskie Partnership reduced its iShares Biotechnology ETF (IBB) stake by 21% in Q2 2026, selling an estimated $240K and leaving 5,280 shares worth $1M. The position accounts for 0.38% of the portfolio, ranked #51.

Raelipskie Partnership first reported a position in IBB in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.87M in Q3 2024. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Raelipskie Partnership held 5,280 shares of iShares Biotechnology ETF worth $1M as of Q2 2026.
Raelipskie Partnership sold 1,395 iShares Biotechnology ETF shares in Q2 2026, an estimated $240K.
iShares Biotechnology ETF made up 0.38% of Raelipskie Partnership's portfolio in Q2 2026, its #51 holding.
Raelipskie Partnership first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 11 quarters since.
Raelipskie Partnership's iShares Biotechnology ETF position peaked at $9.87M in Q3 2024.
957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Raelipskie Partnership's 13F filing for Q2 2026, filed 4 Aug 2026.